Tiangang Ma

622 total citations
17 papers, 442 citations indexed

About

Tiangang Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Tiangang Ma has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Tiangang Ma's work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Tiangang Ma is often cited by papers focused on MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). Tiangang Ma collaborates with scholars based in China. Tiangang Ma's co-authors include Bingdi Yan, Jinyan Yu, Rui Xin, Zhongsen Ma, Jin Ren, Junling Yang, Ke Wang, Chang Fu Tian, Min Zhao and Xin Di and has published in prestigious journals such as American Journal Of Pathology, Frontiers in Immunology and Cell Cycle.

In The Last Decade

Tiangang Ma

17 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiangang Ma China	12	214	158	79	73	72	17	442
Mingquan Chen China	13	287 1.3×	233 1.5×	53 0.7×	60 0.8×	45 0.6×	28	503
Michail Galanopoulos Greece	12	152 0.7×	99 0.6×	87 1.1×	116 1.6×	116 1.6×	37	543
Tianzhong Yan China	11	172 0.8×	89 0.6×	34 0.4×	35 0.5×	69 1.0×	24	286
Liuhong Shi China	13	185 0.9×	169 1.1×	42 0.5×	28 0.4×	239 3.3×	31	566
Nara Lee South Korea	12	154 0.7×	75 0.5×	23 0.3×	46 0.6×	77 1.1×	51	494
Zuzana Kolková Slovakia	14	140 0.7×	98 0.6×	18 0.2×	30 0.4×	106 1.5×	29	452
Goh Tanaka Japan	11	104 0.5×	38 0.2×	49 0.6×	82 1.1×	149 2.1×	43	376
Tangpeng Xu China	10	74 0.3×	43 0.3×	39 0.5×	48 0.7×	66 0.9×	18	262
Samir Abu‐Gazala Israel	12	113 0.5×	48 0.3×	26 0.3×	55 0.8×	63 0.9×	29	436
Yona Kitay‐Cohen Israel	14	112 0.5×	34 0.2×	41 0.5×	244 3.3×	33 0.5×	44	589

Countries citing papers authored by Tiangang Ma

Since Specialization

Citations

This map shows the geographic impact of Tiangang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiangang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiangang Ma more than expected).

Fields of papers citing papers by Tiangang Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiangang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiangang Ma. The network helps show where Tiangang Ma may publish in the future.

Co-authorship network of co-authors of Tiangang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Tiangang Ma. A scholar is included among the top collaborators of Tiangang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiangang Ma. Tiangang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Li, Huanhuan, et al.. (2023). Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era. Frontiers in Immunology. 14. 1132482–1132482. 11 indexed citations

Ma, Tiangang, et al.. (2021). Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis. Cancer Gene Therapy. 29(1). 87–100. 7 indexed citations

Ma, Tiangang, et al.. (2021). Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis. BMC Infectious Diseases. 21(1). 384–384. 54 indexed citations

Ma, Tiangang, et al.. (2021). HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis. Journal of Experimental & Clinical Cancer Research. 40(1). 71–71. 11 indexed citations

Yu, Jinyan, et al.. (2020). Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Laboratory Investigation. 100(6). 794–800. 88 indexed citations

Ma, Tiangang, et al.. (2019). Tumor-Promoting Activity of Long Noncoding RNA LINC00466 in Lung Adenocarcinoma via miR-144–Regulated HOXA10 Axis. American Journal Of Pathology. 189(11). 2154–2170. 19 indexed citations

Ma, Tiangang, et al.. (2019). An 11 years delayed diagnosis of primary pulmonary diffuse large B cell lymphoma. Chinese Medical Journal. 132(16). 2000–2001. 2 indexed citations

Ma, Tiangang, Yubo Hu, & Bernard Yan. (2019). The Analysis of Non-Invasive Positive Pressure Ventilation in Treating COPD Patients Accompanied with Chronic Respiratory Failure. A3344–A3344. 2 indexed citations

Yu, Jinyan, Shanshan Meng, Fei Wu, et al.. (2018). Maternal exposure to farming environment protects offspring against allergic diseases by modulating the neonatal TLR-Tregs-Th axis. Clinical and Translational Allergy. 8(1). 34–34. 24 indexed citations

10.

Yan, Bingdi, et al.. (2018). IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5. Open Biology. 8(10). 14 indexed citations

11.

Ren, Jin, Jinling Fu, Tiangang Ma, et al.. (2018). LncRNA H19-elevated LIN28B promotes lung cancer progression through sequestering miR-196b. Cell Cycle. 17(11). 1372–1380. 39 indexed citations

12.

Yan, Bingdi, et al.. (2018). A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.. PubMed. 8(8). 1387–1402. 87 indexed citations

13.

Ma, Tiangang, et al.. (2017). Effect of SLC34A2 gene mutation on extracellular phosphorus transport in PAM alveolar epithelial cells. Experimental and Therapeutic Medicine. 15(1). 310–314. 11 indexed citations

14.

Yan, Bingdi, Zhongsen Ma, Shaomin Shi, et al.. (2017). Sulforaphane prevents bleomycin-induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2-related factor-2 activation. Molecular Medicine Reports. 15(6). 4005–4014. 45 indexed citations

15.

Li, Bo, Zhongsen Ma, Xuesong Xu, et al.. (2015). Multi-organ Involvement of Sweet's Syndrome: A Case Report and Literature Review. Internal Medicine. 54(3). 339–343. 7 indexed citations

16.

Ma, Tiangang, et al.. (2014). A Pedigree with Pulmonary Alveolar Microlithiasis: A Clinical Case Report and Literature Review. Cell Biochemistry and Biophysics. 70(1). 565–572. 14 indexed citations

17.

Chen, Peng, Xiuli Wang, Zhongsen Ma, et al.. (2012). Knockdown of HMGN5 Expression by RNA Interference Induces Cell Cycle Arrest in Human Lung Cancer Cells. Asian Pacific Journal of Cancer Prevention. 13(7). 3223–3228. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact